Loomis, Sayles & Company’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-352
Closed -$26.6K 742
2026
Q1
$26.6K Sell
352
-138
-28% -$10.4K ﹤0.01% 663
2025
Q4
$36.5K Sell
490
-18
-4% -$1.31K ﹤0.01% 635
2025
Q3
$34.3K Buy
508
+8
+2% +$531 ﹤0.01% 649
2025
Q2
$32.6K Buy
+500
New +$30K ﹤0.01% 660
2025
Q1
Sell
-808
Closed -$58K 745
2024
Q4
$58K Hold
808
﹤0.01% 637
2024
Q3
$66K Buy
808
+183
+29% +$14.6K ﹤0.01% 599
2024
Q2
$46K Sell
625
-6,939
-92% -$520K ﹤0.01% 638
2024
Q1
$589K Sell
7,564
-77,229
-91% -$5.75M ﹤0.01% 479
2023
Q4
$6.06M Sell
84,793
-70,536
-45% -$4.91M 0.01% 385
2023
Q3
$10.8M Sell
155,329
-11,267
-7% -$851K 0.02% 326
2023
Q2
$13.5M Sell
166,596
-2,712
-2% -$222K 0.02% 300
2023
Q1
$13.7M Sell
169,308
-49,894
-23% -$4.02M 0.02% 284
2022
Q4
$16.4M Sell
219,202
-2,156
-1% -$154K 0.03% 253
2022
Q3
$14.3M Sell
221,358
-21,732
-9% -$1.51M 0.03% 258
2022
Q2
$16.8M Sell
243,090
-3,368
-1% -$250K 0.03% 271
2022
Q1
$18.9M Sell
246,458
-3,252
-1% -$234K 0.03% 299
2021
Q4
$19.1M Sell
249,710
-4,289
-2% -$315K 0.02% 315
2021
Q3
$18.7M Buy
253,999
+157
+0.1% +$11.8K 0.02% 312
2021
Q2
$16.9M Buy
253,842
+69,710
+38% +$4.66M 0.02% 320
2021
Q1
$13.7M Sell
184,132
-19,800
-10% -$1.5M 0.02% 346
2020
Q4
$14.9M Sell
203,932
-5,569
-3% -$393K 0.02% 301
2020
Q3
$13.9M Buy
209,501
+19,529
+10% +$1.24M 0.02% 278
2020
Q2
$10.8M Buy
189,972
+17,046
+10% +$836K 0.02% 296
2020
Q1
$6.07M Sell
172,926
-5,048
-3% -$240K 0.01% 362
2019
Q4
$9.29M Buy
177,974
+7,916
+5% +$394K 0.02% 364
2019
Q3
$8.59M Buy
170,058
+39,583
+30% +$1.95M 0.02% 366
2019
Q2
$6.26M Sell
130,475
-6,558
-5% -$303K 0.01% 392
2019
Q1
$6.63M Buy
137,033
+2,043
+2% +$92.1K 0.01% 403
2018
Q4
$5.55M Sell
134,990
-4,214
-3% -$173K 0.01% 405
2018
Q3
$5.71M Sell
139,204
-13,472
-9% -$545K 0.01% 460
2018
Q2
$6.07M Sell
152,676
-129,904
-46% -$5M 0.01% 511
2018
Q1
$10.6M Sell
282,580
-56,806
-17% -$2.3M 0.02% 406
2017
Q4
$14.5M Buy
339,386
+14,329
+4% +$572K 0.03% 354
2017
Q3
$11.9M Sell
325,057
-30,068
-8% -$1.21M 0.03% 387
2017
Q2
$16.1M Sell
355,125
-43,618
-11% -$1.93M 0.04% 312
2017
Q1
$17M Sell
398,743
-16,733
-4% -$682K 0.04% 302
2016
Q4
$16.7M Sell
415,476
-65,134
-14% -$2.51M 0.04% 316
2016
Q3
$18.7M Sell
480,610
-85,378
-15% -$3.22M 0.05% 278
2016
Q2
$19.6M Buy
565,988
+83,699
+17% +$2.9M 0.05% 274
2016
Q1
$16.6M Sell
482,289
-12,024
-2% -$419K 0.05% 324
2015
Q4
$19.1M Sell
494,313
-98,568
-17% -$3.84M 0.05% 300
2015
Q3
$23.2M Sell
592,881
-333,443
-36% -$13.2M 0.07% 239
2015
Q2
$35.3M Sell
926,324
-17,168
-2% -$601K 0.1% 180
2015
Q1
$31.2M Sell
943,492
-20,242
-2% -$621K 0.09% 216
2014
Q4
$25.8M Sell
963,734
-2,592
-0.3% -$66.9K 0.07% 248
2014
Q3
$23.5M Sell
966,326
-48,901
-5% -$1.23M 0.07% 258
2014
Q2
$25.7M Sell
1,015,227
-32,863
-3% -$768K 0.07% 263
2014
Q1
$22.5M Sell
1,048,090
-32,979
-3% -$711K 0.06% 310
2013
Q4
$24.2M Sell
1,081,069
-7,835
-0.7% -$173K 0.07% 278
2013
Q3
$22.5M Sell
1,088,904
-832,213
-43% -$17.7M 0.07% 286
2013
Q2
$37.1K Buy
+1,921,117
New +$40.1M 0.13% 178

Other funds holding HOLX

Loomis, Sayles & Company's HOLX Position: Q2 2026 in Review

Loomis, Sayles & Company sold out of Hologic (HOLX) in Q2 2026, closing a stake of 352 shares — an estimated $26.6K sold.

Loomis, Sayles & Company first reported a position in HOLX in Q2 2013 and held it in 51 quarters. The position peaked at $35.3M in Q2 2015. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Loomis, Sayles & Company reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Loomis, Sayles & Company sold 352 Hologic shares in Q2 2026, an estimated $26.6K.
  • Loomis, Sayles & Company first reported a position in Hologic in Q2 2013 and held it in 51 quarters.
  • Loomis, Sayles & Company's Hologic position peaked at $35.3M in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.